Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 5, 2014, Pages 606-613

  Siegerink, B ^a   Rosendaal, F R ^a   Algra, A ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Utrecht Medical Center   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coagulation factors; Factor XII; Myocardial infarction; Stroke; Women

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; PREKALLIKREIN; ANTIGEN; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLOOD LEVEL; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; ADOLESCENT; BLOOD; CEREBROVASCULAR ACCIDENT; IMMUNOLOGY; ISCHEMIA; MIDDLE AGED; PHYSIOLOGY; RISK; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS; CASE-CONTROL STUDIES; FACTOR XI; FACTOR XII; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIA; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREKALLIKREIN; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84901229243     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12531     Document Type: Article

References (38)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-209.
2. Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15.
3. Farsetti A, Misiti S, Citarella F, Felici A, Andreoli M, Fantoni A, Sacchi A, Pontecorvi A. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 1995; 136: 5076-83.
4. Maas C, Renné T. Regulatory mechanisms of the plasma contact system. Thromb Res 2012; 129: S73-6.
5. Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009; 139: 1143-56.
6. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903-8.
7. Maas C, Govers-Riemslag JWP, Bouma B, Schiks B, Hazenberg BPC, Lokhorst HM, Hammarström P, ten Cate H, de Groot PG, Bouma BN, Gebbink MFBG. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008; 118: 3208-18.
8. Maas C, Oschatz C, Renné T. The plasma contact system 2.0. Semin Thromb Hemost 2011; 37: 375-81.
9. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90: 3819-43.
10. Kitchens CS. The contact system. Arch Pathol Lab Med 2002; 126: 1382-6.
11. Konings J, Govers-Riemslag JWP, Philippou H, Mutch NJ, Borissoff JI, Allan P, Mohan S, Tans G, ten Cate H, Ariëns RAS. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood 2011; 118: 3942-51.
12. Emsley J, McEwan PA, Gailani D. Structure and function of factor XI. Blood 2010; 115: 2569-77.
13. Bouma BN, Meijers JC. Role of blood coagulation factor XI in downregulation of fibrinolysis. Curr Opin Hematol 2000; 7: 266-72.
14. Pedicord D, Seiffert D, Blat Y. Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci USA 2007; 104: 12855-60.
15. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011; 118: 6963-70.
16. Maas C, Meijers JCM, Marquart JA, Bakhtiari K, Weeterings C, de Groot PG, Urbanus RT. Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma. Proc Natl Acad Sci USA 2010; 107: 9083-7.
17. Kluft C, Trumpi-Kalshoven MM, Jie AF, Veldhuyzen-Stolk EC. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Thromb Haemost 1979; 41: 756-73.
18. Jespersen J, Munkvad S, Pedersen OD, Gram J, Kluft C. Evidence for a role of factor XII-dependent fibrinolysis in cardiovascular diseases. Ann N Y Acad Sci 1992; 667: 454-6.
19. Schmaier A. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int Immunopharmacol 2008; 8: 161-5.
20. Schmaier AH. The elusive physiologic role of factor XII. J Clin Invest 2008; 118: 3006-9.
21. Colman R, Clowes A, Goldhaber S, Marder V, George J. Hemostasis and Thrombosis; Basic Principles and Clinical Practice, 5th edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 2006.
22. Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008; 111: 4113-17.
23. Salomon O, Steinberg DM, Dardik R, Rosenberg N, Zivelin A, Tamarin I, Ravid B, Berliner S, Seligsohn U. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003; 1: 658-61.
24. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U. Patients with severe factor XI deficiency have a reduced incidence of deep vein thrombosis. Thromb Haemost 2011; 105: 269-73.
25. Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 2007; 5: 1143-8.
26. Govers-Riemslag JWP, Smid M, Cooper JA, Bauer KA, Rosenberg RD, Hack CE, Hamulyak K, Spronk HMH, Miller GJ, ten Cate H. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 2007; 5: 1896-903.
27. Doggen CJM, Rosendaal FR, Meijers JCM. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood 2006; 108: 4045-51.
28. Merlo C, Wuillemin WA, Redondo M, Furlan M, Sulzer I, Kremer-Hovinga J, Binder BR, Lämmle B. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis 2002; 161: 261-7.
29. Undas A, Slowik A, Gissel M, Mann KG, Butenas S. Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events. Eur J Clin Invest 2012; 42: 123-9.
30. Konings J, Govers-Riemslag JWP, Spronk HMH, Waltenberger JL, ten Cate H. Activation of the contact system in patients with a first acute myocardial infarction. Thromb Res 2013; 132: 138-42.
31. Wuillemin WA, Minnema M, Meijers JC, Roem D, Eerenberg AJ, Nuijens JH, ten Cate H, Hack CE. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. Blood 1995; 85: 1517-26.
32. Siegerink B, Govers-Riemslag JWP, Rosendaal FR, Ten Cate H, Algra A. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation 2010; 122: 1854-61.
33. Kemmeren JM, Tanis BC, van den Bosch MAAJ, Bollen ELEM, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33: 1202-8.
34. Tanis BC, van den Bosch MAAJ, Kemmeren JM, Manger Cats VM, Helmerhorst FM, Algra A, van der Graaf Y, Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001; 345: 1787-93.
35. van den Bosch MAAJ, Kemmeren JM, Tanis BC, Mali WPTM, Helmerhorst FM, Rosendaal FR, Algra A, van Der Graaf Y. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost 2003; 1: 439-44.
36. Tanis BC, Algra A, van der Graaf Y, Helmerhorst FM, Rosendaal FR. Procoagulant factors and the risk of myocardial infarction in young women. Eur J Haematol 2006; 77: 67-73.
37. Löwenberg EC, Meijers JCM, Monia BP, Levi M. Coagulation factor XI as a novel target for antithrombotic treatment. J Thromb Haemost 2010; 8: 2349-57.
38. Younis HS, Crosby J, Huh J-I, Lee HS, Rime S, Monia B, Henry SP. Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys. Blood 2012; 119: 2401-8.